Gilead Sciences

Remdesivir approved by FDA as 1st drug to treat COVID-19

In this March 2020 photo provided by Gilead Sciences, rubber stoppers are placed onto filled vials of the investigational drug remdesivir at a Gilead manufacturing site in the United States. Given through an IV, the medication is designed to interfere with an enzyme that reproduces viral genetic material. (Gilead Sciences via AP)

Top Gilead Sciences Headlines

Gilead’s $2,340 price for coronavirus drug remdesivir …

Vials of the drug remdesivir lie during a press conference about the start of a study with the Ebola drug in Hamburg, northern Germany on April 8, 2020. (ULRICH PERREY/POOL/AFP via Getty Images)

Drug proved effective against novel coronavirus in major …

One vial of the drug remdesivir is displayed during a press conference at the University Hospital Eppendorf in Hamburg, northern Germany on April 8, 2020. (ULRICH PERREY/POOL/AFP via Getty Images)

Stocks charge higher as drugmaker reports early progress …

The New York Stock Exchange near Wall Street is seen on April 25, 2020 in New York City. (Justin Heiman/Getty Images)

Study investigating remdesivir as COVID-19 treatment shows …

One vial of the drug Ebola drug Remdesivir is seen during a press conference about the start of a study with severely ill patients at the University Hospital Eppendorf in Hamburg, Germany on April 8, 2020. (ULRICH PERREY/POOL/AFP via Getty Images)

COVID-19 patients rush to join trials of experimental …

Vials are seen in an image posted to a page on the Gilead Sciences website with information on the remdesivir drug trial on April 4, 2020.

Biotech Companies Are Testing Drugs, Working on Vaccines …

Travelers wearing face masks arrive from various provinces at the Beijing Railway Station on February 3, 2020. (Credit: Noel Celis/AFP/Getty Images)